1. Home
  2. SLDP vs RCKT Comparison

SLDP vs RCKT Comparison

Compare SLDP & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Power Inc.

SLDP

Solid Power Inc.

HOLD

Current Price

$3.12

Market Cap

662.3M

Sector

Energy

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.78

Market Cap

534.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLDP
RCKT
Founded
2011
1999
Country
United States
United States
Employees
230
202
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
662.3M
534.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SLDP
RCKT
Price
$3.12
$3.78
Analyst Decision
Strong Buy
Buy
Analyst Count
2
14
Target Price
$7.00
$29.73
AVG Volume (30 Days)
3.2M
4.2M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$48.90
$69.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.04
$2.19
52 Week High
$8.86
$8.26

Technical Indicators

Market Signals
Indicator
SLDP
RCKT
Relative Strength Index (RSI) 49.14 46.58
Support Level $2.94 $2.99
Resistance Level $3.22 $4.08
Average True Range (ATR) 0.15 0.31
MACD 0.05 -0.03
Stochastic Oscillator 78.07 24.51

Price Performance

Historical Comparison
SLDP
RCKT

About SLDP Solid Power Inc.

Solid Power Inc develops solid-state battery technology and manufacturing processes. Its sulfide-based solid electrolyte material replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells and enables improvement in energy density, battery life and safety performance. The company produces electrolytes on two pilot manufacturing lines using a batch manufacturing process for customer sampling and internal cell development, and manufactures solid-state cells on pre-pilot and pilot cell manufacturing lines. Its cell manufacturing processes are developed around industry-standard lithium-ion battery manufacturing processes and equipment, and it manufactures all cell designs, including cathodes and anodes, using materials sourced from external suppliers.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: